<DOC>
	<DOCNO>NCT02109679</DOCNO>
	<brief_summary>To investigate bioavailability BI 187004 metformin concomitant multiple oral administration 240 mg BI 187004 q.d . 1000 mg metformin b.i.d . comparison BI 187004 metformin give alone .</brief_summary>
	<brief_title>Relative Bioavailability Multiple Oral Doses BI 187004 Metformin After Co-administration Compared Multiple Oral Doses BI 187004 Alone Metformin Alone Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<criteria>Inclusion criterion : 1 . Healthy male subject 2 . Subjects must able understand comply study requirement 3 . Age 18 50 year 4 . Body mass index ( BMI ) 18.5 29.9 kg/m2 Exclusion criterion : 1 . Any finding medical examination ( include BP , pulse rate ( PR ) ECG ) deviate normal judge clinically relevant investigator 2 . Repeated measurement systolic blood pressure outside range 90 140 mmHg diastolic blood pressure outside range 50 90 mmHg , pulse rate outside range 50 90 bpm 3 . Any laboratory value outside reference range investigator considers clinical relevance 4 . Any evidence concomitant disease judge clinically relevant investigator 5 . Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder 6 . Surgery gastrointestinal tract could interfere kinetics trial medication ( except appendectomy simple hernia repair ) 7 . Diseases central nervous system ( epilepsy ) , neurological disorder psychiatric disorder</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>